This possibility was in fact confirmed in two different (4T1 and TUBO) breast cancer murine models for a combination of anti-PD-L1 (pembrolizumab) with Zn-pyrophosphate (ZnP) NPs loaded with the photosensitizer pyrolipid (ZnP@pyrolipid) + PDT. Here, CD274 is linked to breast carcinoma.